Sign in
Taking people in United StatesNo phase

Use of Nicotine Pouches Among Daily Smokers

Key facts

Who runs it
Milton S. Hershey Medical Center
Where
Hershey and Houston, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
375 people, planned
Started
17 Sept 2024
Expected to end
Aug 2028
Type of study
Interventional, 6 groups
Treatments tested
  • 0 mg nicotine pouch
  • 3 mg nicotine pouch
  • 6 mg nicotine pouch
  • Smooth nicotine pouch
  • Wintergreen nicotine pouch
Record updated
20 October 2026

Who can take part

Age
21 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Commonly smoke ≥ 5 cigarettes per day (at least 2 days/week) for at least the prior 12 months
  • Exhaled CO measurement of ≥ 6 parts per million at baseline
  • Must be interested in reducing cigarette consumption by at least 50% and willing to try nicotine pouches
  • Able to understand, read and write in English
  • Access to e-mail and a smartphone/computer that has reliable internet connection
  • Able to understand and give informed consent

Who cannot take part

  • Recent (past 3 months) unstable illness that may increase risks of participation or ability to participate fully (e.g. hospitalization for a mental health condition or substance use disorder in prior 6 months, stroke or myocardial infarction in the past year)
  • Use of illegal drugs daily or weekly in the past 3 months
  • Serious current respiratory diseases (e.g. exacerbations of asthma or chronic obstructive pulmonary disease [COPD], requiring oxygen or oral prednisone), kidney disease (e.g. requiring dialysis), liver disease (e.g cirrhosis), or any medical disorder/medication that may affect participant safety or biomarker data
  • Any other condition that in the opinion of the investigator would make it unlikely that the participant could comply with the study protocol
  • Plans to quit smoking within the next 30 days
  • Currently pregnant, breastfeeding, or planning to become pregnant in the next 6 months
  • Use of a nicotine pouch or other non-cigarette nicotine product (e-cigarette, pipe, cigar, chew, snus, hookah, IQOS) for 5 or more days in the past 28 days
  • Use of combustible (smoked) recreational or medical marijuana weekly in the past 3 months (less frequent smoked medical marijuana or use of other forms of medical marijuana are ok)
  • Other member of the household currently participating in the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 70 years old?

Where in United States

  • Penn State College of MedicineHershey, United StatesContact: Nicolle M Krebs, MSTaking people
  • University of Texas - MD Anderson Cancer CenterHouston, United StatesContact: Jason Robinson, PhDTaking people

About the trial

What the trial wants to find out

The purpose of this clinical trial is to understand the health effects of a new oral nicotine pouch, and also to understand if this product can help reduce traditional cigarette smoking. The main aims are:

Read full original descriptionShow less

1. Understand the impact of nicotine pouch use on toxicant exposure biomarkers, and indicators of potential harms to health. 2. Examine the influence of nicotine pouch use on conventional tobacco product use (cigarettes).

Participants will be randomized to one of six nicotine pouch groups (3 nicotine strengths, each with 2 potential flavors) to use over 16 weeks and asked to reduce their cigarette smoking over that time by at least 75% by substituting with the use of the nicotine pouches. Researchers will compare the outcomes of the different nicotine pouch strengths and flavors to each other. Participants will be asked to complete study questionnaires and provide urine, exhaled carbon monoxide, and mouth cell samples, and other health measurements.

The 6 groups in the trial

  • 0 mg + Smooth flavorTreatment being tested

    Participants are provided with zero strength (0 mg) nicotine pouches with smooth flavor.

    Treatment: 0 mg nicotine pouch and Smooth nicotine pouch

  • 3 mg + Smooth flavorTreatment being tested

    Participants are provided with medium strength (3 mg) nicotine pouches with smooth flavor.

    Treatment: 3 mg nicotine pouch and Smooth nicotine pouch

  • 6 mg + Smooth flavorTreatment being tested

    Participants are provided with high strength (6 mg) nicotine pouches with smooth flavor.

    Treatment: 6 mg nicotine pouch and Smooth nicotine pouch

  • 0 mg + Wintergreen flavorTreatment being tested

    Participants are provided with zero strength (0 mg) nicotine pouches with wintergreen flavor.

    Treatment: 0 mg nicotine pouch and Wintergreen nicotine pouch

  • 3 mg + Wintergreen flavorTreatment being tested

    Participants are provided with medium strength (3 mg) nicotine pouches with wintergreen flavor.

    Treatment: 3 mg nicotine pouch and Wintergreen nicotine pouch

  • 6 mg + Wintergreen flavorTreatment being tested

    Participants are provided with high strength (6 mg) nicotine pouches with wintergreen flavor.

    Treatment: 6 mg nicotine pouch and Wintergreen nicotine pouch

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Placebo-controlled Trial of Nicotine Pouches in Smokers
Fit questions
Built from NCT06043362, who can take part
Record updated
20 October 2026